Breast cancer after mantle irradiation for Hodgkin’s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2
- 1 February 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (2) , 539-546
- https://doi.org/10.1016/s0360-3016(00)01481-4
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Current perspectives on radiation-induced breast cancer.Journal of Clinical Oncology, 1998
- Late mortality of long-term survivors of childhood cancer.Journal of Clinical Oncology, 1997
- Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcomeBlood, 1996
- Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's DiseaseNew England Journal of Medicine, 1996
- Second solid malignancies after combined modality therapy for Hodgkin's disease.Journal of Clinical Oncology, 1995
- Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.Journal of Clinical Oncology, 1995
- Second cancer risk following Hodgkin's disease: a 20-year follow-up study.Journal of Clinical Oncology, 1994
- Breast Cancer After Treatment of Hodgkin's DiseaseJNCI Journal of the National Cancer Institute, 1993
- Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients.Journal of Clinical Oncology, 1992
- Cancer in the Contralateral Breast after Radiotherapy for Breast CancerNew England Journal of Medicine, 1992